Arteris raises FY 2026 revenue outlook to $95M-$98M as ACV plus royalties targets $102M-$106M
Arteris has raised its revenue forecast for the fiscal year 2026 to between $95M and $98M, and has set its ACV and royalty targets at between $102M and $106M.
The current price of $31.62 is positioned in the middle of the range between the 20-day low of $26.63 and the high of $35.76. With trading volume accompanying the misalignment of moving averages, we are monitoring the potential breakout of the resistance level and considering an entry.
If the stock reaches the resistance level of $35.76, I will take profits, and if it falls below the support level of $26.63, I will cut losses — I will monitor the potential breakout of the resistance level and respond with a take profit at $35.76 and a stop loss at $26.63.
RSI(14) 51.6, moving averages are not aligned, trading volume is 1.73 times the 20-day average, recent 7-day volatility +9.2%
At the time of the forecast, the potential for a breakout above the resistance level was supported by an upward revision in guidance and trading volume that was 1.73 times the 20-day average. However, the outcome resulted in a loss of -11.6%, leading to a FAILED designation. The current price of $31.62 was positioned in the middle of the range between the 20-day low ($26.63) and high ($35.76), and despite the moving averages being misaligned, the stock failed to maintain the downward support level and was pushed lower.
Through this trading activity, we confirmed that entering the middle of a range while the moving averages are misaligned can be vulnerable to volatility. In the future, we will not rely solely on simple increases in trading volume or positive news; instead, we will more conservatively monitor whether the stop-loss price ($26.63) is breached during non-aligned periods and thoroughly reflect risk management.